An HIV-1 clade C DNA prime, NYVAC boost vaccine regimen induces reliable, polyfunctional, and long-lasting T cell responses

The Journal of Experimental Medicine
Alexandre HarariGiuseppe Pantaleo

Abstract

The EuroVacc 02 phase I trial has evaluated the safety and immunogenicity of a prime-boost regimen comprising recombinant DNA and the poxvirus vector NYVAC, both expressing a common immunogen consisting of Env, Gag, Pol, and Nef polypeptide domain from human immunodeficiency virus (HIV)-1 clade C isolate, CN54. 40 volunteers were randomized to receive DNA C or nothing on day 0 and at week 4, followed by NYVAC C at weeks 20 and 24. The primary immunogenicity endpoints were measured at weeks 26 and 28 by the quantification of T cell responses using the interferon gamma enzyme-linked immunospot assay. Our results indicate that the DNA C plus NYVAC C vaccine regimen was highly immunogenic, as indicated by the detection of T cell responses in 90% of vaccinees and was superior to responses induced by NYVAC C alone (33% of responders). The vaccine-induced T cell responses were (a) vigorous in the case of the env response (mean 480 spot-forming units/10(6) mononuclear cells at weeks 26/28), (b) polyfunctional for both CD4 and CD8 T cell responses, (c) broad (the average number of epitopes was 4.2 per responder), and (d) durable (T cell responses were present in 70% of vaccinees at week 72). The vaccine-induced T cell responses were str...Continue Reading

References

Mar 10, 2001·Nature·P ChampagneG Pantaleo
Jun 26, 2001·Science·B SchwartländerS Bertozzi
Jan 17, 2002·Journal of Immunological Methods·Jeffrey R CurrierJosephine H Cox
Oct 23, 2002·The Journal of Immunology : Official Journal of the American Association of Immunologists·Zdenek HelGenoveffa Franchini
Dec 17, 2003·The Journal of Experimental Medicine·Souheil-Antoine YounesRafick-Pierre Sekaly
Jan 30, 2004·Annual Review of Medicine·John W Shiver, Emilio A Emini
Mar 3, 2004·Nature Medicine·Ronald C Desrosiers
Mar 23, 2004·Annual Review of Immunology·Federica SallustoAntonio Lanzavecchia
Aug 21, 2004·Journal of Acquired Immune Deficiency Syndromes : JAIDS·Punnee PitisuttithumDonald P Francis
Nov 6, 2004·The Journal of Immunology : Official Journal of the American Association of Immunologists·Vincent HollChristiane Moog
Jan 7, 2005·The Journal of Immunology : Official Journal of the American Association of Immunologists·Alexandre HarariGiuseppe Pantaleo
May 6, 2005·Proceedings of the National Academy of Sciences of the United States of America·Simone C ZimmerliGiuseppe Pantaleo
May 12, 2005·Current Opinion in Immunology·Antonio Lanzavecchia, Federica Sallusto
Mar 23, 2006·Annual Review of Immunology·Andrew J McMichael
Apr 20, 2006·Nature Reviews. Immunology·Giuseppe Pantaleo, Alexandre Harari
Jul 11, 2006·Immunological Reviews·Alexandre HarariGiuseppe Pantaleo
Nov 18, 2006·Nature Immunology·Jonathan L Heeney, Stanley A Plotkin
Nov 25, 2006·Nature Reviews. Immunology·Norman L Letvin
May 18, 2007·The New England Journal of Medicine·Margaret I Johnston, Anthony S Fauci
May 31, 2007·The Journal of Experimental Medicine·Melissa L PrecopioRichard A Koup
Jul 1, 2006·Current Opinion in HIV and AIDS·Pierre-Alexandre BartGiuseppe Pantaleo

❮ Previous
Next ❯

Citations

Aug 4, 2010·Immunology and Cell Biology·Paweena RattanasenaAndreas Suhrbier
Sep 29, 2011·Molecular Therapy : the Journal of the American Society of Gene Therapy·Krystle A Lang KuhsDavid B Weiner
Oct 4, 2008·Nature·Dan H Barouch
Feb 18, 2010·Proceedings of the National Academy of Sciences of the United States of America·Godwin NchindaRalph M Steinman
Jan 16, 2008·The Journal of Experimental Medicine·Rafick-Pierre Sekaly
Sep 24, 2008·The Journal of Infectious Diseases·Eric SandströmUNKNOWN HIV Immunogenicity Study 01/02 Team
Jul 3, 2008·AIDS Research and Human Retroviruses·Graeme B JacobsSusan Engelbrecht
Jun 22, 2012·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Stephen M FeinstoneMarian E Major
Feb 2, 2011·The Journal of Infectious Diseases·Paul A GoepfertUNKNOWN National Institute of Allergy and Infectious Diseases HIV Vaccine Trials Network
Oct 28, 2010·Current Opinion in HIV and AIDS·Jerome H KimNelson L Michael
Oct 28, 2010·Current Opinion in HIV and AIDS·Hélène PerrinLydie Trautmann
Oct 28, 2010·Current Opinion in HIV and AIDS·Georgia D Tomaras, Barton F Haynes
Apr 20, 2011·Current Opinion in HIV and AIDS·Filippos Porichis, Daniel E Kaufmann
Sep 10, 2010·Journal of Virology·Helga Hofmann-SieberRalf Wagner
Jul 22, 2011·Journal of Virology·Matthieu PerreauGiuseppe Pantaleo
Apr 8, 2011·Journal of Virology·Philomena KamyaUNKNOWN Canadian Cohort of HIV Infected Slow Progressors
Mar 3, 2010·Annual Review of Immunology·John R Mascola, David C Montefiori
Jan 12, 2010·Annual Review of Medicine·Dan H Barouch, Bette Korber
Jan 2, 2009·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Cornelia L TrimbleT C Wu
Sep 9, 2009·Journal of Immune Based Therapies and Vaccines·Ronald B Moss
Jul 23, 2013·Retrovirology·Torben SchiffnerLucy Dorrell
Jul 4, 2008·Retrovirology·Enrico IaccinoGiuseppe Scala

❮ Previous
Next ❯

Methods Mentioned

BETA
flow cytometry
ELISA
myristylation

Software Mentioned

DiVa
GENEART
SPICE
CELLQuest
GeneOptimizer

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.